In the SURMOUNT-1 trial, Tirzepatide produced average weight reductions of 15.0%, 19.5%, and 20.9% at weekly doses of 5 mg, 10 mg, and 15 mg respectively, over 72 weeks (Jastreboff et al., NEJM 2022
Safety and side effects Peptides can offer significant health benefits, but like any other biologically active therapy, they can cause some side effects
At Frontier Peptide Labs, quality control is built around accurate analytical testing, peptide identity verification, assay testing, and transparent laboratory standards
The adverse events that did occur were predominantly mild, self-limiting, and occurred at rates comparable to placebo groups